Viewing Study NCT00663832


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-02-24 @ 5:58 AM
Study NCT ID: NCT00663832
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2008-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module